We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
United Research Laboratories, Inc. and Mutual Pharmaceutical Company, Inc. ("Mutual") announce that Mutual has notified Adams Respiratory Therapeutics that Mutual has filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration (FDA) for Mutual's guaifenesin extended-release tablets, 600 mg and 1200 mg, which are the generic equivalent to Adams' Mucinex brand.
Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced that it has filed with securities regulators in Canada and mailed to shareholders the information circular and proxy materials for the shareholders' meeting September 20, 2006 at which INEX will seek approval to spin-out the Company's technology, products, cash and partnerships into Tekmira Pharmaceuticals Corporation ("Tekmira").
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. announced a worldwide multi-target strategic alliance to discover, develop and market novel medicines targeting four chemokine and chemoattractant receptors for the treatment of a variety of inflammatory disorders, including Traficet-EN in late stage development for the treatment of inflammatory bowel disease (IBD).
Attorneys for a woman who claims she was diagnosed with breast cancer after taking Prempro told a federal jury yesterday that drug maker Wyeth ignored repeated signals that the menopause drug could cause breast cancer.
Depomed, Inc. and King Pharmaceuticals, Inc. announced that as they prepare for the launch of Glumetza (metformin hydrochloride extended-release tablets), a new consensus statement was issued from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Canadian drug maker Biovail Corp. said Thursday it is suing
the U.S. Food and Drug Administration to try to stop the agency from approving generic versions of its extended-release antidepressant without addressing issues brought up in a citizen petition.
The Dutch company Akzo Nobel announced that it will call a general meeting of its shareholders to vote on whether to spin off Organon, the firm's pharmaceutical business.
Fresh off an internal report critical of inaccuracies in the FDA's drug data system, the agency is proposing a new rule requiring drug manufacturers to electronically register all their products -- prescription or OTC -- in an Electronic Drug Registration and Listing System (EDRLS).